| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 9 | +66.67% | +0.60% | -0.72% | +1.31% | +9.48% | — |
| 14d | 9 | +66.67% | +7.23% | -1.40% | +8.63% | +16.85% | — |
| 30d | 9 | +55.56% | -4.85% | -1.87% | -2.97% | +8.61% | — |
| 60d | 9 | +11.11% | -7.37% | +4.01% | -11.38% | -11.93% | — |
| 90d | 9 | +11.11% | -10.23% | +1.13% | -11.36% | -13.28% | — |
| 180d | 9 | +11.11% | -37.78% | -1.42% | -36.37% | -56.91% | — |
| 1y | 9 | +11.11% | -44.45% | +2.25% | -46.70% | -46.55% | — |
| 2y | 9(3 pending) | +16.67% | -46.96% | +11.45% | -58.42% | -72.67% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KZIA KAZIA THERAPEUTICS LTD | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Jun 19, 2026 | Jun 23, 2026 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 332,621 | — | — | 1,295,117 | Mar 11, 2025 | Mar 13, 2025 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASE Chief Financial Officer | 2,400 | $5.00 | $12.0K | 67,716 | Dec 18, 2024 | Dec 18, 2024 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASE Chief Financial Officer | 2,752 | $5.42 | $14.9K | 65,316 | Dec 17, 2024 | Dec 18, 2024 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASE Chief Financial Officer | 2,564 | $3.83 | $9.8K | 62,564 | Dec 16, 2024 | Dec 18, 2024 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 205,008 | — | — | 962,496 | Mar 7, 2024 | Mar 7, 2024 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 197,472 | — | — | 757,488 | Mar 15, 2023 | Mar 16, 2023 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASE Chief Financial Officer | 30,000 | $1.56 | $46.7K | 60,000 | Sep 16, 2022 | Sep 19, 2022 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 170,016 | — | — | 560,016 | Mar 9, 2022 | Mar 10, 2022 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASE Chief Financial Officer | 5,000 | $6.75 | $33.8K | 10,000 | Sep 10, 2021 | Sep 13, 2021 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASE Chief Financial Officer | 5,000 | $6.32 | $31.6K | 30,000 | Sep 10, 2021 | Sep 13, 2021 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASE Chief Financial Officer | 5,000 | $6.62 | $33.1K | 5,000 | Sep 10, 2021 | Sep 13, 2021 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASE Chief Financial Officer | 5,000 | $6.35 | $31.8K | 25,000 | Sep 10, 2021 | Sep 13, 2021 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASE Chief Financial Officer | 10,000 | $6.38 | $63.8K | 20,000 | Sep 10, 2021 | Sep 13, 2021 ↗ | View → |
| CRDF CARDIFF ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 390,000 | — | — | 390,000 | Jul 12, 2021 | Jul 12, 2021 ↗ | View → |